Cytotoxicity resulting from addition of HIV-1 Nef N-terminal peptides to yeast and bacterial cells

被引:15
作者
Macreadie, IG [1 ]
Lowe, MG [1 ]
Curtain, CC [1 ]
Hewish, D [1 ]
Azad, AA [1 ]
机构
[1] CSIRO,DIV BIOMOL ENGN,PARKVILLE,VIC 3052,AUSTRALIA
关键词
D O I
10.1006/bbrc.1997.6349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Nef protein of human immunodeficiency type 1 (HIV-1) has been implicated in diverse intracellular functions; however, extracellular functions have been less studied. Nef and the N-terminus of Nef possess membrane-perturbing and fusogenic activities in artificial membranes that also cause cytotoxicity to human cells, including lymphocytes. The present study investigates the toxicity of HIV-1 Nef peptides employing yeast and bacterial cells. The N-terminal portion of Nef was found to cause cell killing in Escherichia coli and in a variety of yeast cells. This activity was enhanced by myristylation of the Nef N-terminus, a modification that did not lead to toxicity in a control peptide. Cell death in yeast was due to permeabilization of the cell membrane as determined by the propidium iodide uptake of peptide-treated cells. Extracellular Nef, or its breakdown products, may have effects similar to the Nef peptides described here and could be responsible, at least in part, for the death of cells in lymphoid tissues during AIDS. Assays using yeast or bacteria are convenient, inexpensive, and robust and should be useful in further analysis and screening of inhibitors of this activity associated with HIV-1 Nef. (C) 1997 Academic Press.
引用
收藏
页码:707 / 711
页数:5
相关论文
共 28 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]  
BAHRAOUI E, 1990, BLOOD, V76, P257
[3]  
CARRASCO L, 1995, ADV VIRUS RES, V45, P61, DOI 10.1016/S0065-3527(08)60058-5
[4]  
CULMANN B, 1991, J IMMUNOL, V146, P1560
[5]   AN ANTIGENIC PEPTIDE OF THE HIV-1 NEF PROTEIN RECOGNIZED BY CYTOTOXIC LYMPHOCYTE-T OF SEROPOSITIVE INDIVIDUALS IN ASSOCIATION WITH DIFFERENT HLA-B MOLECULES [J].
CULMANN, B ;
GOMARD, E ;
KIENY, MP ;
GUY, B ;
DREYFUS, F ;
SAIMOT, AG ;
SERENI, D ;
LEVY, JP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (12) :2383-2386
[6]   FUSOGENIC ACTIVITY OF AMINO-TERMINAL REGION OF HIV TYPE-1 NEF PROTEIN [J].
CURTAIN, CC ;
SEPAROVIC, F ;
RIVETT, D ;
KIRKPATRICK, A ;
WARING, AJ ;
GORDON, LM ;
AZAD, AA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (10) :1231-1240
[7]  
CURTAIN CC, 1997, IN PRESS RES HUMAN R
[8]   GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS [J].
DEACON, NJ ;
TSYKIN, A ;
SOLOMON, A ;
SMITH, K ;
LUDFORDMENTING, M ;
HOOKER, DJ ;
MCPHEE, DA ;
GREENWAY, AL ;
ELLETT, A ;
CHATFIELD, C ;
LAWSON, VA ;
CROWE, S ;
MAERZ, A ;
SONZA, S ;
LEARMONT, J ;
SULLIVAN, JS ;
CUNNINGHAM, A ;
DWYER, D ;
DOWTON, D ;
MILLS, J .
SCIENCE, 1995, 270 (5238) :988-991
[9]   APOPTOSIS OCCURS PREDOMINANTLY IN BYSTANDER CELLS AND NOT IN PRODUCTIVELY INFECTED-CELLS OF HIV-INFECTED AND SIV-INFECTED LYMPH-NODES [J].
FINKEL, TH ;
TUDORWILLIAMS, G ;
BANDA, NK ;
COTTON, MF ;
CURIEL, T ;
MONKS, C ;
BABA, TW ;
RUPRECHT, RM ;
KUPFER, A .
NATURE MEDICINE, 1995, 1 (02) :129-134
[10]   In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4(+) T cells without MHC restriction [J].
Fujii, Y ;
Otake, K ;
Tashiro, M ;
Adachi, A .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :2943-2951